Sarepta Therapeutics, Inc. (SRPT)

23.17 -0.66 (-2.77%) USD  |  NASDAQ  |  Jan 12, 09:55
More

Sarepta Therapeutics Non-Current Deferred Revenue (Quarterly)

Non-Current Deferred Revenue (Quarterly) Chart

View Non-Current Deferred Revenue (Quarterly) for SRPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Deferred Revenue (Quarterly) Benchmarks

View Non-Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
Pfizer Inc. --
Arrowhead Pharmaceuticals, Inc. --
Amgen, Inc. --
Bristol Myers Squibb Co. Upgrade
Alnylam Pharmaceuticals, Inc. --